111 Inc (YI)
1.05
-0.04
(-3.67%)
USD |
NASDAQ |
Apr 24, 16:00
1.08
+0.03
(+2.86%)
After-Hours: 20:00
111 Cash from Investing (TTM): -4.690M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -4.690M |
| June 30, 2023 | 9.808M |
| March 31, 2023 | -18.39M |
| December 31, 2022 | -7.023M |
| September 30, 2022 | 39.27M |
| June 30, 2022 | -13.18M |
| March 31, 2022 | -0.267M |
| December 31, 2021 | 9.314M |
| September 30, 2021 | -50.99M |
| June 30, 2021 | -28.00M |
| Date | Value |
|---|---|
| March 31, 2021 | -33.27M |
| December 31, 2020 | -47.05M |
| September 30, 2020 | 0.538M |
| June 30, 2020 | 42.06M |
| March 31, 2020 | 34.76M |
| December 31, 2019 | 34.41M |
| September 30, 2019 | -93.57M |
| June 30, 2019 | -143.35M |
| March 31, 2019 | -114.09M |
| December 31, 2018 | -120.53M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-143.35M
Minimum
Jun 2019
42.06M
Maximum
Jun 2020
-14.98M
Average
-5.856M
Median
Cash from Investing (TTM) Benchmarks
| Concord Medical Services Holdings Ltd | -- |
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | -- |
| Zai Lab Ltd | -10.78M |
| I-MAB | -- |